References
- References
- Alper G, Jarjour IT, Reyes JD, Towbin RB, Hirsch WL, Bergman I. Outcome of children with cerebral edema caused by fulminant hepatic failure. Pediatr Neurol 1998;18:299–304.
- Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341:157.
- Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995;59:103.
- Zimmer DB, Cornwall EH, Landar A, Song W. The S-100 protein family: history, function and expression. Brain Res Bull 1995;37:417.
- Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E. S-100aO protein in blood and urine during open-heart surgery. Clin Chem 1989;35:1942–4.
- Nygaard Ø, Langbakk B, Romner B. Age-and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 1997;43: 541.
- Butterworth RF. Pathogenesis of acute hepatic encephalopathy. Digestion 1998;59 Suppl 2:16–21.
- Korvald C, Elvenes OP, Ytrebø LM, Sørlie DG, Myrmel T. Oxygen-wasting effect of inotropy in the ‘virtual work model’. Am J Physiol 1999;276:H1339–45.
- Van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta 1974;56:151–7.
- Ingebrigtsen T, Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. J Neurosurg 1996;85:945–8.
- Blei A. Brain edema and intracranial hypertension: a focus for the use of liver support systems. Artif Organs 1997;21:1182–4.
- Lee WM. Acute liver failure. N Engl J Med 1993;329:1862–72.
- Moore BW. A soluble protein characteristic of the nervoussystem. Biochem Biophys Res Commun 1965;19 Suppl 6:73944.
- Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest 1987;57 Suppl 5:489–98.
- Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma 1998;45: 765–7.
- Waterloo K, Ingebrigtsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir Wien 1997;139: 26–31.
- Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997;28: 1961–5.
- Blomquist S, Johnsson P, Luhrs C. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothorac Vasc Anesth 1997;6: 699–703.
- Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 1998;29:473–7.
- Jonsson H, Johnsson P, Alling C, Westaby S, Blomquist S. Significance of serum S100 release after coronary artery bypass grafting. Ann Thorac Surg 1998;65: 1639–44.
- Wiesmann M, Missler U, Hagenström H, Gttmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir Wien 1997;139: 1155.
- Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29: 2363–6.